E2F is required for STAT3-mediated upregulation of cyclin B1 and Cdc2 expressions and contributes to G2-M phase transition.


Journal

Acta biochimica et biophysica Sinica
ISSN: 1745-7270
Titre abrégé: Acta Biochim Biophys Sin (Shanghai)
Pays: China
ID NLM: 101206716

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 04 12 2018
revised: 18 12 2018
pubmed: 7 2 2019
medline: 6 8 2019
entrez: 7 2 2019
Statut: ppublish

Résumé

Activation of transcription factor STAT3 is involved in cell proliferation, differentiation, and cell survival. Constitutive activation of STAT3 pathway has been associated with the oncogenesis of various types of cancers. It has been reported that STAT3 plays a key role in the G1 to S phase cell cycle transition induced by the cytokine receptor subunit gp130, through the upregulation of cyclins D1, D2, D3, A, and Cdc25A and the concomitant downregulation of p21 and p27. However, its role in mediating G2-M phase transition has not been studied. The cyclin B1/Cdc2 complex is widely accepted as the trigger of mitosis in all organisms and is believed to be necessary for progression through S phase and keep active during the G2-M transition and progression. In the present study, we found that activation of STAT3 stimulates cyclin B1 and Cdc2 expressions. Deletion and site-directed mutations on cyclin B1 and Cdc2 promoters indicated that E2F element mediates the upregulation of these two promoters in a STAT3-dependent manner. The findings reported here demonstrated that STAT3 participates in modulating G2-M phase checkpoint by regulating gene expressions of cyclin B1 and Cdc2 via E2F.

Identifiants

pubmed: 30726872
pii: 5307801
doi: 10.1093/abbs/gmy174
doi:

Substances chimiques

CCNB1 protein, human 0
Cyclin B1 0
E2F Transcription Factors 0
STAT3 Transcription Factor 0
STAT3 protein, human 0
CDC2 Protein Kinase EC 2.7.11.22
CDK1 protein, human EC 2.7.11.22

Types de publication

Journal Article

Langues

eng

Pagination

313-322

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Jingjie Sun (J)

School of Life Science, Lanzhou University, Lanzhou, Gans, China.
Lanzhou University Second Hospital, Lanzhou, Gansu, China.

Yuping Du (Y)

School of Life Science, Lanzhou University, Lanzhou, Gans, China.

Qiaoling Song (Q)

School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Innovation Center for Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.

Jing Nan (J)

School of Life Science, Lanzhou University, Lanzhou, Gans, China.

Peizhu Guan (P)

School of Life Science, Lanzhou University, Lanzhou, Gans, China.

Jihui Guo (J)

School of Life Science, Lanzhou University, Lanzhou, Gans, China.

Xiao Wang (X)

School of Life Science, Lanzhou University, Lanzhou, Gans, China.

Jinbo Yang (J)

School of Life Science, Lanzhou University, Lanzhou, Gans, China.
School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Innovation Center for Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.

Chenyang Zhao (C)

School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Innovation Center for Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH